Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis

References

• MurphyGCapliceNMolloyMFractalkine in rheumatoid arthritis: a review to dateRheumatology (Oxford)200847101446145118495821
   PubMed Web of Science ®Google Scholar
• VergunstCEvan de SandeMGLebreMCTakPPThe role of chemokines in rheumatoid arthritis and osteoarthritisScand J Rheumatol200534641542516393761
   PubMed Web of Science ®Google Scholar
• TarrantTKPatelDDChemokines and leukocyte trafficking in rheumatoid arthritisPathophysiology200613111416380240
   PubMedGoogle Scholar
• BrennanFBeechJUpdate on cytokines in rheumatoid arthritisCurr Opin Rheumatol200719329630117414959
   PubMed Web of Science ®Google Scholar
• WellsTNProudfootAEChemokine receptors and their antagonists in allergic lung diseaseInflamm Res199948735336210450784
   PubMed Web of Science ®Google Scholar
• RossiDZlotnikAThe biology of chemokines and their receptorsAnnu Rev Immunol20001821724210837058
   PubMed Web of Science ®Google Scholar
• SzekaneczZSzücsGSzántóSKochAEChemokines in rheumatic diseasesCurr Drug Targets2006719110216454702
   PubMed Web of Science ®Google Scholar
• Goldbach-ManskyRLipskyPENew concepts in the treatment of rheumatoid arthritisAnnu Rev Med20035419721612359827
   PubMed Web of Science ®Google Scholar
• AlldredAEtanercept in rheumatoid arthritisExpert Opin Pharmacother2001271137114811583065
   PubMedGoogle Scholar
• BathonJMMartinRWFleischmannRMA comparison of etanercept and methotrexate in patients with early rheumatoid arthritisN Engl J Med2000343221586159311096165
   PubMed Web of Science ®Google Scholar
• ScottDLKingsleyGHTumor necrosis factor inhibitors for rheumatoid arthritisN Engl J Med2006355770471216914706
   PubMed Web of Science ®Google Scholar
• ArnettFCEdworthySMBlochDAThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum19883133153243358796
   PubMed Web of Science ®Google Scholar
• American College of Rheumatology Subcommittee on Rheumatoid Arthritis GuidelinesGuidelines for the management of rheumatoid arthritis: 2002 updateArthritis Rheum200246232834611840435
   PubMed Web of Science ®Google Scholar
• Van der HeijdeDMvan’t HofMAvan RielPLJudging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity scoreAnn Rheum Dis199049119169202256738
   PubMed Web of Science ®Google Scholar
• OdaiTMatsunawaMTakahashiRCorrelation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritisJ Rheumatol20093661158116519369458
   PubMed Web of Science ®Google Scholar
• KasamaTIsozakiTOdaiTExpression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-alpha and interferon-gammaTransl Res2007149526527317466926
   PubMed Web of Science ®Google Scholar
• ChenXOppenheimJJHowardOMChemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal componentsCell Mol Immunol20041533634216285892
   PubMed Web of Science ®Google Scholar
• FeldmannMBrennanFMWilliamsROElliottMJMainiRNCytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of actionJ Inflamm1995–1996471–29096
   Google Scholar
• CharlesPElliottMJDavisDRegulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritisJ Immunol199916331521152810415055
   PubMed Web of Science ®Google Scholar
• BergLLampaJRogbergSvan VollenhovenRKlareskogLIncreased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptorsAnn Rheum Dis200160213313911156546
   PubMed Web of Science ®Google Scholar
• KlimiukPASierakowskiSDomyslawskaIChwieckoJSerum chemokines in patients with rheumatoid arthritis treated with etanerceptRheumatol Int20091219 Epub ahead of print
   Web of Science ®Google Scholar
• PanYLloydCZhouHNeurotactin, a membrane-anchored chemokine upregulated in brain inflammationNature199738766336116179177350
   PubMed Web of Science ®Google Scholar
• UmeharaHBloomETOkazakiTNaganoYYoshieOImaiTFractalkine in vascular biology: from basic research to clinical diseaseArterioscler Thromb Vasc Biol2004241344012969992
   PubMed Web of Science ®Google Scholar
• ChenSBaconKBLiLIn vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-IIJ Exp Med199818811931989653095
   PubMed Web of Science ®Google Scholar
• HasegawaMSatoSEchigoTHamaguchiYYasuiMTakeharaKUp regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosisAnn Rheum Dis2005641212815608300
   PubMed Web of Science ®Google Scholar
• YajimaNKasamaTIsozakiTElevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestationsArthritis Rheum20055261670167515934075
   PubMed Web of Science ®Google Scholar
• MatsunawaMIsozakiTOdaiTIncreased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitisArthritis Rheum200654113408341617075825
   PubMed Web of Science ®Google Scholar
• MatsunawaMOdaiTWakabayashiKElevated serum levels of soluble CX3CL1 in patients with microscopic polyangiitisClin Exp Rheumatol20092717278
   PubMed Web of Science ®Google Scholar
• RuthJHRottmanJBKatschkeKJJrSelective lymphocyte chemokine receptor expression in the rheumatoid jointArthritis Rheum200144122750276011762935
   PubMed Web of Science ®Google Scholar
• RuthJHVolinMVHainesGK3rdFractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritisArthritis Rheum20014471568158111465708
   PubMed Web of Science ®Google Scholar
• VolinMVWoodsJMAminMAConnorsMAHarlowLAKochAEFractalkine: a novel angiogenic chemokine in rheumatoid arthritisAm J Pathol200115941521153011583978
   PubMed Web of Science ®Google Scholar
• BlaschkeSKoziolekMSchwarzAProinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritisJ Rheumatol20033091918192712966591
   PubMed Web of Science ®Google Scholar
• KageyamaYIchikawaTNagafusaTTorikaiEShimazuMNaganoAEtanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritisRheumatol Int200728213714317619881
   PubMed Web of Science ®Google Scholar
• IchikawaTKageyamaYKobayashiHKatoNTsujimuraKKoideYEtanercept treatment reduces the serum levels of interleukin-15 and interferon-gamma inducible protein-10 in patients with rheumatoid arthritisRheumatol Int201030672573020062995
   PubMed Web of Science ®Google Scholar